Evidence map›Paper›PMID 36105086›Full record

ArticleFrontiers in genetics2022

Experimental verification and validation of immune biomarkers based on chromatin regulators in ischemic stroke.

Beibei Yu, Yunze Tian, Yongfeng Zhang, Boqiang Lv, Jianzhong Li, Shouping Gong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Beibei YuDepartment of Neurourgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Yunze TianDepartment of Neurourgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Yongfeng ZhangDepartment of Neurourgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Boqiang LvDepartment of Neurourgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Jianzhong LiDepartment of Thoracic Surgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Shouping GongDepartment of Neurourgery, the Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Second Affiliated Hospital of Xi'an Jiaotong University · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic stroke (IS) is a disease characterized by rapid progression and high mortality and disability rates. Its pathophysiological process is inseparable from immune dysfunction. Recently, chromatin regulators (CRs) have been described as a class of enzymes that can recognize, form, and maintain the epigenetic state of an organism, and are closely associated with immune regulation. Nevertheless, the role of CR-related genes in IS has not been fully elucidated. In this study, seven CR-related immune biomarkers in the GSE58294 and GSE22255 datasets were identified by combining differential gene expression analysis, weighted correlation network analysis, and single sample gene set enrichment analysis. After experimental validation using quantitative polymerase chain reaction, four genes (

Indexed as

bioinformaticsbiomarkerchromatin regulatorsimmune infiltrationischemic stroke

Identifiers

PMID36105086
PMCPMC9465164
OpenAlexW4293537990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.